REsearching Covid-19 Outcomes in Diabetes (RECODE)

Inclusion criteria

For Type 2 Diabetes (T2D)

• Male or female 18 years of age and older willing and able to give informed consent to participate in the study
• Confirmed diagnosis of SARS-CoV-2 RNA via a polymerase chain reaction (PCR) assay (having been discharged at least 2 months from hospital but not greater than 6 months).
• Diagnosis of T2D according to American Diabetes Association (ADA) criteria.
• Must have access to a computer/laptop or a modern (no more than 3-4 years old) smart phone/tablet for cognitive assessments.

For participant without Type 2 Diabetes (T2D)

• Male or female 18 years of age and older willing and able to give informed consent to participate in the study
• Confirmed diagnosis of SARS-CoV-2 RNA via a polymerase chain reaction (PCR) assay (having been discharged at least 2 months from hospital but not greater than 6 months).
• Must have access to a computer/laptop or a modern (no more than 3-4 years old) smart phone/tablet for cognitive assessments.

Exclusion criteria

• Symptoms of active respiratory viral infection:

• high temperature (over 37.8°C/100.4°F)
• cough (consistent for over an hour; 3 or more episodes in 24 hours)
• Any history of Type I diabetes
• The participant may not enter the study with any known contraindication to magnetic resonance imaging including

• Pregnancy, lactation or 6 months postpartum from the scheduled date of collection
• Metal implants (pacemaker, aneurysm clips) based on Investigator's judgment at Screening
• Unable to participate in MRI assessments due to physical limitations of equipment tolerances (e.g. MRI bore size) based on Investigator's judgment at Screening
• Unable to tolerate MRI imaging or claustrophobia
• Any condition, including a significant underlying disease or disorder which, in the opinion of the investigator, may put the participant at risk by participating in the study or limit the participant's ability to participate.